Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke.
Apolipoprotein E (ApoE), a cholesterol transporter and an immunomodulator, is brain protective after experimental stroke and implicated in brain repair. Here, we study the involvement of ApoE in the restoration of brain function after experimental stroke, by using animal housing conditions that differentially improve recovery after occlusion of the middle cerebral artery occlusion (MCAO). We found that after MCAO the ApoE levels increased in the injured hemisphere over a 30 days recovery period. The exception was a proximal narrow peri-infarct rim, in which ApoE was solely localized in S100beta(+)/glial fibrillary acidic protein (GFAP) negative reactive astrocytes at 4 to 7 days of recovery. Enriched housing after MCAO caused a marked decrease in ApoE levels compared with standard housing conditions, particularly in the ApoE/S100beta(+) reactive astrocytes. In addition, the levels of interleukin 1beta were lower in animals housed in an enriched environment. We propose that during the subacute phase after experimental stroke a zone for tissue reorganization with low cellular ApoE levels is formed. We conclude that the strong sensori-motor stimulation provided by enriched housing conditions mitigates the inflammatory response after stroke decreasing the level of ApoE that may contribute to the observed improvement of functional recovery.
Ruscher
Karsten
K
Department of Clinical Sciences, Laboratory for Experimental Brain Research, Wallenberg Neuroscience Center, University of Lund, Lund, Sweden. karsten.ruscher@med.lu.se
Johannesson
Emelie
E
Brugiere
Elena
E
Erickson
Agnes
A
Rickhag
Mattias
M
Wieloch
Tadeusz
T
D000818:Animals; D001057:Apolipoproteins E / Q000378:metabolism*; D001253:Astrocytes / Q000378:metabolism* / Q000473:pathology; D001522:Behavior, Animal / Q000502:physiology; D015153:Blotting, Western; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D020520:Brain Infarction / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D002452:Cell Count; D004660:Encephalitis / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D004777:Environment; D004797:Enzyme-Linked Immunosorbent Assay; D006799:Housing, Animal / Q000592:standards; D007150:Immunohistochemistry; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D020521:Stroke / Q000150:complications / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology
D001057:Apolipoproteins E